Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

All participants reported receiving phosphate supplementation and active vitamin D (Pi/D)-based therapy, a regimen that has long been recognized to have limited efficacy and to be associated with adherence challenges and treatment-related complications.15,16 While Pi/D therapy aims to improve biochemical abnormalities: primarily by reducing alkaline phosphatase levels and maintaining PTH within the normal range: complete normalization of serum phosphate is not typically achieved.

Source: Current management experiences. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Qualitative study.

Qualitative study

Examines experiences or meanings using qualitative methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study

Source: Article title.

Eligible patients were identified and invited by treating physicians at participating centers based on clinical records and ongoing care in specialized endocrinology and genetics clinics.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study

Qualitative study · JBMR Plus · 2026

Original publication title

Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study

Shih-Yao Liu; Yi-Ching Tung; Chia-Chi Hsu; Yu-Yuan Ke; Ying-Hua Huang; Tun-Ying Hsu; Annie Chin; Ben Johnson; Wen-Yu Tsai

© The Author(s) 2026. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

X-linked hypophosphatemia (XLH) is a rare, lifelong disorder of renal phosphate wasting that typically presents in childhood with skeletal deformities, growth retardation, and functional impairment, although these features may be less pronounced in milder cases. The disease persists into adulthood with chronic pain, mobility limitations, and psychosocial challenges. While pediatric XLH has been well described internationally, the lifelong disease journey in Taiwan remains poorly characterized. We conducted a multicenter qualitative study using semi-structured, in-depth interviews between July 2024 and January 2025 at 3 major medical centers, enrolling 15 patients with a clinical diagnosis of XLH (genetically confirmed in a subset): 8 pediatric patients (aged ≥5 yr) interviewed with caregivers and 7 adults interviewed independently.

Interviews (~60 min) explored diagnostic pathways, treatment experiences, disease burden, and support needs; transcripts were analyzed thematically. Participants commonly reported delayed or missed diagnosis, with early symptoms such as bowed legs and short stature often misattributed to nutritional or growth-related issues, leading to late referral to specialist care. Oral phosphate supplementation and active vitamin D (Pi/D) were the predominant treatments; however, frequent dosing, poor palatability, and gastrointestinal side effects contributed to low adherence. Many adults had discontinued therapy, and 12 patients underwent corrective limb surgery, mainly during childhood or adolescence.

Across the life course, patients experienced chronic bone pain, reduced mobility, and insufficiency fractures, as well as psychosocial burdens, including anxiety, low self-esteem, social withdrawal, and caregiver stress, often compounded by guilt related to hereditary transmission. Patients and caregivers emphasized unmet needs in disease education, transition from pediatric to adult care, peer support, and interest in novel therapies, such as burosumab. These findings highlight substantial lifelong disease burden among patients with XLH in Taiwan and underscore the need for earlier diagnosis, multidisciplinary care, and improved access to emerging therapies.

Authors’ abstract

Abstract

X-linked hypophosphatemia (XLH) is a rare, lifelong disorder of renal phosphate wasting that typically presents in childhood with skeletal deformities, growth retardation, and functional impairment, although these features may be less pronounced in milder cases. The disease persists into adulthood with chronic pain, mobility limitations, and psychosocial challenges. While pediatric XLH has been well described internationally, the lifelong disease journey in Taiwan remains poorly characterized. We conducted a multicenter qualitative study using semi-structured, in-depth interviews between July 2024 and January 2025 at 3 major medical centers, enrolling 15 patients with a clinical diagnosis of XLH (genetically confirmed in a subset): 8 pediatric patients (aged ≥5 yr) interviewed with caregivers and 7 adults interviewed independently.

Interviews (~60 min) explored diagnostic pathways, treatment experiences, disease burden, and support needs; transcripts were analyzed thematically. Participants commonly reported delayed or missed diagnosis, with early symptoms such as bowed legs and short stature often misattributed to nutritional or growth-related issues, leading to late referral to specialist care. Oral phosphate supplementation and active vitamin D (Pi/D) were the predominant treatments; however, frequent dosing, poor palatability, and gastrointestinal side effects contributed to low adherence. Many adults had discontinued therapy, and 12 patients underwent corrective limb surgery, mainly during childhood or adolescence.

Across the life course, patients experienced chronic bone pain, reduced mobility, and insufficiency fractures, as well as psychosocial burdens, including anxiety, low self-esteem, social withdrawal, and caregiver stress, often compounded by guilt related to hereditary transmission. Patients and caregivers emphasized unmet needs in disease education, transition from pediatric to adult care, peer support, and interest in novel therapies, such as burosumab. These findings highlight substantial lifelong disease burden among patients with XLH in Taiwan and underscore the need for earlier diagnosis, multidisciplinary care, and improved access to emerging therapies.

Publication and source details

Original title: Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study

Shih-Yao Liu; Yi-Ching Tung; Chia-Chi Hsu; Yu-Yuan Ke; Ying-Hua Huang; Tun-Ying Hsu; Annie Chin; Ben Johnson; Wen-Yu Tsai

JBMR Plus · 2026

Corresponding authors: Shih-Yao Liu and Wen-Yu Tsai, Department of Pediatric Endocrinology, National Taiwan University Hospital, No. 7, Zhongshan South Road, Taipei 10051, Taiwan (syliu2008@ntuh.gov.tw; wenyutsai@ntu.edu.tw).© The Author(s) 2026. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Kyowa Kirin Taiwan

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:28:35.391851+00:00

DOI: 10.1093/jbmrpl/ziag163 · PMC13695141